Moxifloxacin-associated neutropenia

Scand J Infect Dis. 2013 May;45(5):415-6. doi: 10.3109/00365548.2012.738937. Epub 2012 Nov 15.

Abstract

A 32-y-old woman presented with pneumonia. Treatment was started with moxifloxacin. On day 2 of moxifloxacin treatment the patient developed neutropenia. After discontinuing the moxifloxacin, neutrophil counts were normal on day 4. Clinicians should be aware of the possibility of this adverse effect in patients treated with moxifloxacin.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Aza Compounds / adverse effects*
  • Aza Compounds / therapeutic use
  • Female
  • Fluoroquinolones
  • Humans
  • Leukocyte Count
  • Moxifloxacin
  • Neutropenia / chemically induced*
  • Pneumonia / blood
  • Pneumonia / drug therapy
  • Quinolines / adverse effects*
  • Quinolines / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin